Global Liver Institute CEO Praises U.S. House Subcommittee, Organ Procurement Organization Action to Help Transplant Patients (Washington, D.C., Tuesday, May 4, 2021)—Donna Cryer, president and CEO...
(Washington, D.C., Friday, April 30, 2021)—Two witnesses from Global Liver Institute (GLI) will testify at a key U.S. House of Representatives subcommittee hearing on the need to...
(Washington, D.C., April 13, 2021) – Global Liver Institute (GLI) and many of the leaders of the liver, diabetes and obesity advocacy community have submitted a formal letter and comments to...
(Washington, D.C., March 4, 2021) – Global Liver Institute (GLI) is pleased to announce that the 2021 International NASH Day (#NASHday) will be held on June 10, 2021, with the...
As more Americans have received at least one dose of a COVID-19 vaccine than have tested positive for the virus1, we are seeing some hope for defeating the pandemic with science. While different...
(Washington, D.C., February 18, 2021) Today, Global Liver Institute (GLI) submitted a letter directly to U.S. Department of Health and Human Services (HHS) Secretary-Designee Xavier...
POLICY PERSPECTIVE The 2020 election not only resulted in a new president and vice president, but also 66 new Members of Congress. The 117th Congress will have 57 new U.S. Representatives from 28...
(Washington, D.C., February 1, 2021) – Global Liver Institute (GLI), in their mission to improve the lives of individuals and families impacted by liver disease, has announced February 2021 as...
(Washington, D.C., January 29, 2021) Thank you to the Food and Drug Administration (FDA) for the informative briefing earlier today titled, “Regulatory Perspectives for Development of Drugs for...
(Washington, D.C., January 25, 2021) On January 21, DC Health announced the plan to open up vaccine access, possibly as soon as February, to an expansive population including habitual smokers...
Recent News
Congress is entering the August recess period. Nevertheless, patients are increasingly signaling to policymakers their frustration related to coverage challenges and over-zealous utilization management practices such as non-medical switching and other barriers...
NASH Affects Millions, But the Future for Treatment Remains Brighter Than Ever Managing NASH/MASH is becoming more promising with new advancements. The recent FDA approval of resmetirom, which offers hope for those with moderate-to-advanced liver scarring, marks...
Thank you for reading Liver Cancer News! Liver cancer is associated with low five-year survival rates, often due to late-stage diagnosis of the disease. In many cases, symptoms are minimal or absent until the cancer has progressed significantly, at which point...
New App Helps Predict Pediatric Transplant Need Amplify your voice with the new Wilson’s disease advocacy toolkit Following the Policy brief on Wilson’s disease in 2023, the Health Partnership has officially published their Wilson’s disease advocacy...
Global Fatty Liver Day 2024 was a huge success! Check out our "At a Glance" report for highlights. Stay tuned for the full Global Fatty Liver Day 2024 report. Endocrinologists and PCPs: The Frontline Defense Against Cirrhosis in Patients with Type 2...
